MENU
LGHT
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

LGHT stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
LGHT
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for LGHT with price predictions
Sep 11, 2026

Momentum Indicator for LGHT turns negative, indicating new downward trend

LGHT saw its Momentum Indicator move below the 0 level on September 04, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator turned negative. In 43 of the 50 cases, the stock moved further down in the following days. The odds of a decline are at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for LGHT moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 similar instances where the indicator moved out of overbought territory. In 8 of the 10 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

The Moving Average Convergence Divergence Histogram (MACD) for LGHT turned negative on September 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 25 similar instances when the indicator turned negative. In 21 of the 25 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 50-day moving average for LGHT moved above the 200-day moving average on September 09, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +0.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where LGHT advanced for three days, in 70 of 98 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

LGHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 62 of 100 cases where LGHT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Intuitive Surgical (NASDAQ:ISRG), Moderna (NASDAQ:MRNA), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Teladoc Health (NYSE:TDOC).

Industry description

The investment seeks long-term growth of capital. Under normal circumstances, the fund will invest at least 80% of the fund’s net assets (plus borrowings for investment purposes) in U.S. and foreign exchange-listed equity securities of healthcare technology companies and American Depository Receipts (“ADRs”) on those securities. These securities may be of any market capitalization. The fund is non-diversified.

Market Cap

The average market capitalization across the Langar Global HealthTech ETF ETF is 18.07B. The market cap for tickers in the group ranges from 393.58M to 130.41B. ISRG holds the highest valuation in this group at 130.41B. The lowest valued company is TBRG at 393.58M.

High and low price notable news

The average weekly price growth across all stocks in the Langar Global HealthTech ETF ETF was -4%. For the same ETF, the average monthly price growth was 5%, and the average quarterly price growth was 3%. PGNY experienced the highest price growth at 5%, while TNDM experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Langar Global HealthTech ETF ETF was 16%. For the same stocks of the ETF, the average monthly volume growth was -10% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 66
Price Growth Rating: 53
SMR Rating: 72
Profit Risk Rating: 95
Seasonality Score: -38 (-100 ... +100)
View a ticker or compare two or three
LGHT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
116 South Franklin StreetP. O. Box 69Rocky Mount
Phone
252-972-9922
Web
N/A